Banco Santander’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.19M | Sell |
10,845
-655
| -6% | -$243K | 0.03% | 231 |
|
|
2026
Q1 | $3.37M | Buy |
11,500
+2,818
| +32% | +$926K | 0.03% | 228 |
|
|
2025
Q4 | $3.04M | Sell |
8,682
-330
| -4% | -$112K | 0.02% | 239 |
|
|
2025
Q3 | $2.91M | Buy |
9,012
+723
| +9% | +$225K | 0.03% | 246 |
|
|
2025
Q2 | $3.22M | Sell |
8,289
-28,233
| -77% | -$11.4M | 0.03% | 231 |
|
|
2025
Q1 | $15.9M | Buy |
36,522
+738
| +2% | +$296K | 0.18% | 94 |
|
|
2024
Q4 | $13.2M | Sell |
35,784
-5,900
| -14% | -$2.47M | 0.16% | 102 |
|
|
2024
Q3 | $21.7M | Buy |
41,684
+4,117
| +11% | +$2.2M | 0.26% | 72 |
|
|
2024
Q2 | $20.4M | Sell |
37,567
-2,687
| -7% | -$1.42M | 0.25% | 62 |
|
|
2024
Q1 | $20.9M | Sell |
40,254
-4,989
| -11% | -$2.48M | 0.25% | 58 |
|
|
2023
Q4 | $21.3M | Buy |
45,243
+2,678
| +6% | +$1.24M | 0.25% | 54 |
|
|
2023
Q3 | $18.5M | Buy |
42,565
+24,779
| +139% | +$11.2M | 0.26% | 60 |
|
|
2023
Q2 | $7.9M | Buy |
17,786
+12,396
| +230% | +$5.72M | 0.1% | 122 |
|
|
2023
Q1 | $2.48M | Sell |
5,390
-1,727
| -24% | -$822K | 0.04% | 166 |
|
|
2022
Q4 | $3.65M | Sell |
7,117
-2,728
| -28% | -$1.39M | 0.05% | 148 |
|
|
2022
Q3 | $4.47M | Sell |
9,845
-697
| -7% | -$334K | 0.06% | 142 |
|
|
2022
Q2 | $5.09M | Sell |
10,542
-2,428
| -19% | -$1.2M | 0.07% | 139 |
|
|
2022
Q1 | $6.37M | Buy |
12,970
+303
| +2% | +$139K | 0.07% | 159 |
|
|
2021
Q4 | $5.87M | Buy |
12,667
+1,970
| +18% | +$829K | 0.03% | 156 |
|
|
2021
Q3 | $3.99M | Buy |
10,697
+674
| +7% | +$256K | 0.02% | 187 |
|
|
2021
Q2 | $3.83M | Sell |
10,023
-1,239
| -11% | -$473K | 0.02% | 191 |
|
|
2021
Q1 | $4.04M | Sell |
11,262
-95
| -0.8% | -$30.6K | 0.03% | 157 |
|
|
2020
Q4 | $3.65M | Sell |
11,357
-14,070
| -55% | -$4.32M | 0.03% | 158 |
|
|
2020
Q3 | $6.83M | Buy |
25,427
+13,617
| +115% | +$3.66M | 0.09% | 94 |
|
|
2020
Q2 | $3.1M | Sell |
11,810
-2,543
| -18% | -$678K | 0.04% | 131 |
|
|
2020
Q1 | $3.26M | Sell |
14,353
-2,367
| -14% | -$645K | 0.04% | 174 |
|
|
2019
Q4 | $5.05M | Sell |
16,720
-40,157
| -71% | -$11.1M | 0.05% | 137 |
|
|
2019
Q3 | $13.7M | Buy |
56,877
+39,963
| +236% | +$10.9M | 0.13% | 75 |
|
|
2019
Q2 | $4.77M | Sell |
16,914
-63,216
| -79% | -$17.3M | 0.05% | 142 |
|
|
2019
Q1 | $23M | Buy |
80,130
+65,884
| +462% | +$19.1M | 0.26% | 41 |
|
|
2018
Q4 | $3.74M | Buy |
14,246
+2,281
| +19% | +$627K | 0.05% | 162 |
|
|
2018
Q3 | $3.28M | Buy |
11,965
+1,645
| +16% | +$427K | 0.04% | 175 |
|
|
2018
Q2 | $2.46M | Buy |
10,320
+739
| +8% | +$171K | 0.03% | 185 |
|
|
2018
Q1 | $2.11M | Buy |
9,581
+2,278
| +31% | +$535K | 0.02% | 199 |
|
|
2017
Q4 | $1.64M | Sell |
7,303
-690
| -9% | -$147K | 0.02% | 131 |
|
|
2017
Q3 | $1.51M | Sell |
7,993
-588
| -7% | -$112K | 0.03% | 135 |
|
|
2017
Q2 | $1.62M | Buy |
+8,581
| New | +$1.54M | 0.03% | 107 |
|
Other funds holding ELV
AACR
Banco Santander's ELV Position: Q2 2026 in Review
Banco Santander reduced its Elevance Health (ELV) stake by 5.7% in Q2 2026, selling an estimated $243K and leaving 10,845 shares worth $4.19M. The position accounts for 0.03% of the portfolio, ranked #231.
Banco Santander first reported a position in ELV in Q2 2017 and has held it in 37 quarters since. The position peaked at $23M in Q1 2019. 917 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Banco Santander held 10,845 shares of Elevance Health worth $4.19M as of Q2 2026.
- Banco Santander sold 655 Elevance Health shares in Q2 2026, an estimated $243K.
- Elevance Health made up 0.03% of Banco Santander's portfolio in Q2 2026, its #231 holding.
- Banco Santander first reported a position in Elevance Health in Q2 2017 and has held it in 37 quarters since.
- Banco Santander's Elevance Health position peaked at $23M in Q1 2019.
- 917 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Banco Santander's 13F filing for Q2 2026, filed 29 Jul 2026.